BRCA2 and breast carcinoma: To determine whether the inter-individual variations noted above are linked to the risk of developing breast cancer, we next generated cells from prophylactic mastectomy tissues from various risk groups including four BRCA1-mutant carriers and three cases of BRCA2-mutant carriers.